Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Haupt

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
JAMA|October 16, 2024
FTC Regulation of AI-Generated Medical DisinformationClaudia E Haupt, Mason Marks
JAMA|March 27, 2023
AI-Generated Medical Advice-GPT and BeyondClaudia E Haupt, Mason Marks
Life (Chicago, Ill. : 1978)|May 1, 1985
Bill's heart: the troubling story behind a historic experimentJeff Wheelright, Donna E Haupt
Deutsche Medizinische Wochenschrift (1946)|March 1, 1974
[The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]E Haupt, J Beyer, K Schöffling
AMA Journal of Ethics|March 3, 2023
Holding Clinicians in Public Office Accountable to Professional StandardsWendy E Parmet, Claudia E Haupt
Medizinische Klinik|July 8, 1977
[Cost-benefit analyses of the employment of assistant dieticians by medical practitioners. 1st report: Basic considerations, calculatory basis, analysis of a policlinical research study and preliminary assessment of an in-practice project (author's transl)]R Petzoldt, E Haupt, K Schöffling
Klinische Wochenschrift|April 1, 1970
[In-vitro changes of the serum binding capacity for 131 I-insulin under tolbutamide and glybenclamide in normal persons, in juvenile and senile diabetes, as well as in insulin resistance]K Schemmel, E Haupt, K Leybold
International Journal of Clinical Pharmacology and Therapeutics|February 25, 2005
Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study)E Haupt, H Ledermann, W Köpcke
Deutsche Medizinische Wochenschrift (1946)|July 22, 1977
[Attempted suicide using glibenclamide--also a contribution to the characterization of sulfonylurea effect]E Haupt, R Petzoldt, K Schöffling
Arzneimittel-Forschung|March 1, 1974
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]E Haupt, J Beyer, K Schöffling
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
JAMA|October 16, 2024
FTC Regulation of AI-Generated Medical DisinformationClaudia E Haupt, Mason Marks
JAMA|March 27, 2023
AI-Generated Medical Advice-GPT and BeyondClaudia E Haupt, Mason Marks
Life (Chicago, Ill. : 1978)|May 1, 1985
Bill's heart: the troubling story behind a historic experimentJeff Wheelright, Donna E Haupt
Deutsche Medizinische Wochenschrift (1946)|March 1, 1974
[The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]E Haupt, J Beyer, K Schöffling
AMA Journal of Ethics|March 3, 2023
Holding Clinicians in Public Office Accountable to Professional StandardsWendy E Parmet, Claudia E Haupt
Medizinische Klinik|July 8, 1977
[Cost-benefit analyses of the employment of assistant dieticians by medical practitioners. 1st report: Basic considerations, calculatory basis, analysis of a policlinical research study and preliminary assessment of an in-practice project (author's transl)]R Petzoldt, E Haupt, K Schöffling
Klinische Wochenschrift|April 1, 1970
[In-vitro changes of the serum binding capacity for 131 I-insulin under tolbutamide and glybenclamide in normal persons, in juvenile and senile diabetes, as well as in insulin resistance]K Schemmel, E Haupt, K Leybold
International Journal of Clinical Pharmacology and Therapeutics|February 25, 2005
Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study)E Haupt, H Ledermann, W Köpcke
Deutsche Medizinische Wochenschrift (1946)|July 22, 1977
[Attempted suicide using glibenclamide--also a contribution to the characterization of sulfonylurea effect]E Haupt, R Petzoldt, K Schöffling
Arzneimittel-Forschung|March 1, 1974
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]E Haupt, J Beyer, K Schöffling
Pageof 11